| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.100.11.1148 |
| P698 | PubMed publication ID | 10484532 |
| P50 | author | Paul Ridker | Q7153226 |
| P2093 | author name string | Libby P | |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 1148-1150 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Novel inflammatory markers of coronary risk: theory versus practice. | |
| P478 | volume | 100 |
| Q80938093 | -717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study |
| Q90233295 | A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia |
| Q36263222 | A Pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia |
| Q40384012 | A cost-effectiveness analysis of a hypothetical catheter-based strategy for the detection and treatment of vulnerable coronary plaques with drug-eluting stents |
| Q84590972 | A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin |
| Q46496524 | Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes |
| Q73129026 | Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients |
| Q35937166 | An Elevated Value of C-Reactive Protein is the Only Predictive Factor of Restenosis after Percutaneous Coronary Intervention |
| Q36830230 | Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality |
| Q28279892 | Antiapoptotic and proapoptotic signaling of cyclophilin A in endothelial cells |
| Q40559496 | Antimicrobial Periodontal Treatment Decreases Serum C‐Reactive Protein, Tumor Necrosis Factor‐Alpha, But Not Adiponectin Levels in Patients with Chronic Periodontitis |
| Q45971261 | Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease. |
| Q37632519 | Association between depression and inflammation--differences by race and sex: the META-Health study |
| Q37689003 | Association between serum amyloid A and obesity: a meta-analysis and systematic review |
| Q44088443 | Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus |
| Q84149041 | Association of promoter region single nucleotide polymorphisms at positions -819C/T and -592C/A of interleukin 10 gene with ischemic heart disease |
| Q33838255 | Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA). |
| Q77931320 | Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention |
| Q53972592 | Associations between change in C-reactive protein and serum lipids during statin treatment. |
| Q37382729 | Atheroprotective effects of pure tocotrienol supplementation in the treatment of rabbits with experimentally induced early and established atherosclerosis. |
| Q33981208 | Beyond Self-Reports: Changes in Biomarkers as Predictors of Mortality |
| Q38079565 | Biomarkers in atrial fibrillation: a clinical review |
| Q37703930 | Blood pressure in adolescence, adipokines and inflammation in young adults. The rio de janeiro study |
| Q51729364 | C-reactive protein and myocardial infarction during percutaneous coronary intervention. |
| Q92462734 | Carpinus turczaninowii extract modulates arterial inflammatory response: a potential therapeutic use for atherosclerosis |
| Q35544330 | Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction |
| Q74452801 | Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty |
| Q35974401 | Chronic osteomyelitis increases long-term mortality risk in the elderly: a nationwide population-based cohort study. |
| Q34695711 | Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses |
| Q34319876 | Clinical trials: surrogate endpoints or hard endpoints? |
| Q30627641 | Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes |
| Q35126464 | Coronary artery disease: New insights into the pathophysiology, prevalence and early detection of a monster menace |
| Q42628291 | Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. |
| Q90335726 | Design and Synthesis of Aza-/Oxa Heterocycle-Based Conjugates as Novel Anti-Inflammatory Agents Targeting Cyclooxygenase-2 |
| Q44282682 | Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur studies of successful aging |
| Q51789171 | Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens. |
| Q42164961 | Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus |
| Q28166582 | Effect of tirofiban on C-reactive protein in non-ST-elevation myocardial infarction |
| Q34691265 | Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease |
| Q34675610 | Effects of high versus low-dose atorvastatin on high sensitive C-reactive protein in acute coronary syndrome |
| Q44166478 | Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen |
| Q58137696 | Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels |
| Q53969633 | Endothelial inflammation and thrombolysis resistance in acute myocardial infarction. |
| Q42249823 | Epstein-Barr virus antibody titer and its association with the domain scores from the World Health Organization's Quality of Life questionnaire: Findings from Rural Hainan Province, China |
| Q37223680 | Gender differences in stimulated cytokine production following acute psychological stress |
| Q35944843 | Genomic and proteomic determinants of lower extremity revascularization failure: rationale and study design |
| Q35197876 | Growth hormone and cardiovascular risk markers |
| Q36732731 | Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study |
| Q34133528 | HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study. |
| Q42473006 | Heat-shock response is associated with decreased production of interleukin-6 in murine aortic vascular smooth muscle cells |
| Q33979763 | High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone |
| Q40279372 | High-sensitivity C-reactive protein, adiposity, and blood pressure in the Yakut of Siberia |
| Q64239061 | How stress mediators can cumulatively contribute to Alzheimer's disease An allostatic load approach |
| Q33824735 | Immunology: improving on nature in the twenty-first century |
| Q42261013 | Impact of lifestyle changes on stress in a modernizing rural population in Hainan Island, China |
| Q53920487 | Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. |
| Q34089724 | Inflammation, a Link between Obesity and Cardiovascular Disease |
| Q34428150 | Inflammatory pathways in atherosclerosis and acute coronary syndromes |
| Q36086859 | Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor |
| Q77104440 | Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction |
| Q44724551 | Is serum uric acid level associated with all-cause mortality in high-functioning older persons: MacArthur studies of successful aging? |
| Q35945137 | Is there any Relationship Between C-Reactive Protein Level and Complex Coronary Plaques in Patients with Unstable Angina? |
| Q40570359 | Ischemia Modified Albumin (IMA) - A Marker of Glycaemic Control and Vascular Complications in Type 2 Diabetes Mellitus |
| Q44170460 | Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians |
| Q46423373 | Lifestyle incongruity, stress and immune function in indigenous Siberians: the health impacts of rapid social and economic change |
| Q33915449 | Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus |
| Q34443175 | Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target |
| Q35020304 | Management of intermittent claudication |
| Q37650090 | Markers of inflammation and cardiovascular disease: clinical applications of C-reactive protein determination |
| Q83031262 | Measurement of cumulative physiological dysregulation in an older population |
| Q92000753 | Novel Antiatherosclerotic Therapies |
| Q37096929 | Optimal risk factor modification and medical management of the patient with peripheral arterial disease |
| Q35969365 | Oral health, atherosclerosis, and cardiovascular disease |
| Q33818137 | Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A |
| Q33958905 | Pathophysiological events during pregnancy influence the development of atherosclerosis in humans. |
| Q36986373 | Patients at high risk for ischemic stroke: identification and actions. |
| Q42519503 | Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. |
| Q40582543 | Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study |
| Q77120486 | Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation |
| Q33304394 | Prevalence of coronary artery disease risk factors in Iran: a population based survey |
| Q33857984 | Prevention of coronary heart disease. Part II. Secondary prevention, detection of subclinical disease, and emerging risk factors |
| Q50074049 | Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence. |
| Q49242577 | Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-κB signaling pathway in hyperlipidemic rabbits |
| Q77931282 | Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease |
| Q34497022 | Resistance exercise training-induced muscle hypertrophy was associated with reduction of inflammatory markers in elderly women |
| Q73739845 | Restenosis after coronary intervention: narrowing C-reactive protein's prognostic potential? |
| Q30310670 | Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes |
| Q24594814 | Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective |
| Q36726951 | Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study |
| Q28219344 | Serial changes in plasma levels of cytokines in patients with coronary artery disease |
| Q46789865 | Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism |
| Q35946426 | Social relationships and inflammatory markers: an analysis of Taiwan and the U.S. |
| Q77335557 | Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation |
| Q34989692 | Statins and C-reactive protein: considering a novel marker of cardiovascular risk |
| Q93938951 | Still life in oxidation hypothesis of atherogenesis |
| Q58761419 | Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based |
| Q36363692 | Suppression of Nitric Oxide Production and Cardiovascular Risk Factors in Healthy Seniors and Hypercholesterolemic Subjects by a Combination of Polyphenols and Vitamins |
| Q47909748 | Temporal association of elevated C-reactive protein and periodontal disease in men. |
| Q30377003 | The Frequency and Energy of Snoring Sounds Are Associated with Common Carotid Artery Intima-Media Thickness in Obstructive Sleep Apnea Patients |
| Q30892742 | The Inflammatory Heart Diseases: Causes, Symptoms, and Treatments |
| Q58209963 | The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling |
| Q37290138 | The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate |
| Q33839207 | The pathophysiology of acute coronary syndromes |
| Q36430041 | The predictive value of C-reactive protein in end-stage renal disease: is it clinically significant? |
| Q34011157 | The role of C-reactive protein in cardiovascular disease risk |
| Q34327214 | The use of statins in acute coronary syndromes: the mechanisms behind the outcomes |
| Q39525817 | The utilization of carotid artery imaging beyond metabolic scores and high-sensitivity CRP in screening intermediate-to-high Framingham risk of asymptomatic Taiwanese population |
| Q36052956 | Thiazolidinediones and cardiovascular disease |
| Q46917492 | Time course of rapid C-reactive protein reduction by pravastatin in patients with stable angina |
| Q34468200 | Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice |
| Q35172646 | Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. |
| Q36025968 | Utility of statin therapy using high-sensitivity C-reactive protein as an indicator of coronary heart disease risk |
| Q28253143 | Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors |
| Q73540801 | [Genetic risk factors for myocardial infarct] |
| Q74451978 | [Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-q-wave myocardial infarction] |
Search more.